[1]
D. . Samatkyzy, “Development of a Clinical Trial Protocol for the Use of a Dual GIP/GLP-1 Receptor Agonist in Patients with Heart Failure with Preserved Ejection Fraction”, Eurasian Journal of Applied Biotechnology, no. 3s, Nov. 2025.